SMN2 and spinal muscular atrophy: Suppression of a strong ISS motif with the intent to induce exon re-inclusion has been previously investigated as a therapeutic strategy in ApoER2, GAA and SMN2 genes, which underlie Alzheimer disease, Pompe disease and spinal muscular atrophy, respectively32–34.